Exonuclease-mediated ELISA-like assay for detecting DNA-binding activity of transcription factors: Measurement of activated NF-κB

BioTechniques

Volumn 41, Issue 1, 2006, Pages 79-90

  Wang, Jinke ^a   Li, Min L ^a   Hua, Dong ^a   Chen, Qixin ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b HENAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BIOTECHNOLOGY; DNA; ENZYME KINETICS; ESTERS; PROTEINS;

DNA BINDING ACTIVITY;

BIOASSAY;

ALKALINE PHOSPHATASE; ANTIBODY; CELL EXTRACT; DIGOXIGENIN; DNA; DNA BINDING PROTEIN; DOUBLE STRANDED DNA; EXODEOXYRIBONUCLEASE III; EXONUCLEASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SUCCINIMIDE DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; EXODEOXYRIBONUCLEASE; OLIGONUCLEOTIDE;

ANTIBODY LABELING; ARTICLE; CONJUGATION; DNA BINDING; DNA PROBE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; HUMAN; HUMAN CELL; MEASUREMENT; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SAMPLING; SEQUENCE ANALYSIS; BIOASSAY; BIOLOGICAL MODEL; CELL NUCLEUS; CHEMISTRY; GENETIC PROCEDURES; HELA CELL; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; BIOLOGICAL ASSAY; CELL NUCLEUS; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXODEOXYRIBONUCLEASES; EXONUCLEASES; GENETIC TECHNIQUES; HELA CELLS; HUMANS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NF-KAPPA B; OLIGONUCLEOTIDES; TRANSCRIPTION FACTORS;

EID: 33747592634     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000112218     Document Type: Article

References (57)

1. Sen, R. and D. Baltimore. 1986. Inducibility of immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism. Cell 47:921-928.
2. Baeuerle, P.A. and D. Baltimore. 1996. NF-κB: ten years after. Cell 87:13-20.
3. Lenardo, M.J. and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227-229.
4. Baldwin, A.S., Jr. 1996. The NF-kappa B and 1 kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
5. Baldwin, A.S., Jr. 2001. Series introduction: the transcription factor NF-kappaB and human disease. J. Clin. Invest. 107:3-6.
6. Epinat, J.C., E.L. Dvorin, and T.D. Gilmore. 1999. Diverse agents act at multiple levels to inhibit the Rel/NF-kappa B signal transduction pathway. Oncogene 18:6896-6909.
7. Perkins, N.D. 2000. The Rel/NF- kappa B family: friend and foe. Trends Biochem. Sci. 25:434-440.
8. Garg, A. and B.B. Aggarwal. 2002. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 16:1053-1068.
9. Kunsch, C., S.M. Ruben, and C.A. Rosen. 1992. Selection of optimal kappaB/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
10. Schmid, R.M., S. Liptay, J.C. Betts, and G.J. Nabel. 1994. Structural and functional analysis of NF- kappa B. Determinants of DNA binding specificity and protein interaction. J. Biol. Chem. 269:32162-32167.
11. Renard, P., I. Ernest, A. Houbion, M. Art, H.L. Calvezl, M. Raes, and J. Remacle. 2001. Development of a sensitive multi-well colorimetric assay for active NF-κB. Nucleic Acids Res. 29:e21.
12. Rosenau, C., D. Emery, B. Kaboord, and M.W. Qoronfleh. 2004. Development of a high-throughput plate-based chemiluminescent transcription factor assay. J. Biomol. Screen. 9:334-342.
13. Gupta, S.V., R.M. McGowen, D.M. Callewaert, T.R. Brown, Y. Li, and F.H. Sarkar. 2005. Quantitative chemiluminescent immunoassay for NF-kappaB-DNA binding activity. J. Immunoassay Immunochem. 26:125-143.
14. Wang, J.K., T.X. Li, X.Y. Guo, and Z.H. Lu. 2005. Exonuclease III protection assay with FRET probe for detecting DNA-binding proteins. Nucleic Acids Res. 33:e23.
15. DiDonato, J.A., M. Hayakawa, D.M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IkappaB kinase that activates the transcription factor NF- kappaB. Nature 388:548-554.
16. Adcock, I.M. 1997. Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Arch. Chest Dis. 52:178-186.
17. Sreedhar, A.S. and U.K. Srinivas. 2002. Activation of stress response by ionomycin in rat hepatoma cells. J. Cell. Biochem. 86:154-161.
18. Rogers, S.G. and B. Weiss. 1980. Exonuclease III of Escherichia coli K-12, an AP endonuclease. Methods Enzymol. 65:201-211.
19. Wu, C. 1985. An exonuclease protection assay reveals heat-shock element and TATA box binding proteins in crude nuclear extracts. Nature 317:84-87.
20. Bohmann, D., T.J. Bos, A. Admon, T. Nishimura, P.K. Vogt, and R. Tjian. 1987. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386-1392.
21. Nakabeppu, Y. and D. Nathans. 1989. The basic region of Fos mediates specific DNA binding. EMBO J. 8:3833-3841.
22. Wu, C. 1980. The 5′ ends of Drosophila heat shock genes in chromatin are hypersensitive to DNase I. Nature 286:854-860.
23. Wu, C. 1984. Two protein-binding sites in chromatin implicated in the activation of heat-shock genes. Nature 309:229-234.
24. Ng, R. and J. Carbon. 1987. Mutational and in vitro protein-binding studies on centromere DNA from Saccharomyces cerevisiae. Mol. Cell. Biol. 7:4522-4534.
25. Gilmour, D.S., T.J. Dietz, and S.C.R. Elgin. 1988. TATA box-dependent protein-DNA interactions are detected on heat shock and histone gene promoters in nuclear extracts derived from Drosophila melanogaster embryos. Mol. Cell. Biol. 8:3204-3214.
26. de Vries, E., W. van Driel, W.G. Bergsma, A.C. Arnberg, and P.C. van der Vliet. 1989. HeLa nuclear protein recognizing DNA termini and translocating on DNA forming a regular DNA-multimeric protein complex. J. Mol. Biol. 208:65-78.
27. Henikoff, S. 1984. Unidirectional digestion with exonuclease 111 creates targeted break-points for DNA sequencing. Gene 28:351-359.
28. Guo, L.H. and R. Wu. 1982. New rapid methods for DNA sequencing based on exo-nuclease III digestion followed by repair synthesis. Nucleic Acids Res. 10:2065-2084.
29. Vandeyar, M., M.P. Weiner, C. Hutton, and C. Batt. 1988. A simple and rapid method for the selection of oligodeoxynucleotide-directed mutants. Gene 65:129-133.
30. Li, C. and R.M. Evans. 1997. Ligation independent cloning irrespective of restriction site compatibility. Nucleic Acids Res. 25:4165-4166.
31. Shalloway, D., T. Kleinberger, and D.M. Livingston. 1980. Mapping of SV40 DNA replication origin region binding sites for the SV40 T antigen by protection against exonuclease III digestion. Cell 20:411-422.
32. Siebenlist, U., R.B. Simpson, and W. Gilbert. 1980. Escherichia coli RNA polymerase interacts homologously with two different promoters. Cell 20:269-281.
33. Siebenlist, U. and W. Gilbert. 1980. Contacts between Escherichia coli RNA polymerase and an early promoter of phage T7. Proc. Natl. Acad. Sci. USA 77:122-126.
34. Carey, M., H. Kakidani, J. Leatherwood, F. Mostashari, and M. Ptashne. 1989. An amino-terminal fragment of GAL4 binds DNA as a dimer. J. Mol. Biol. 209:423-432.
35. Loh, T.P., L.L. Sievert, and R.W. Scott. 1990. Evidence for a stem cell-specific repressor of Moloney murine leukemia virus expression in embryonic carcinoma cells. Mol. Cell. Biol. 10:4045-4057.
36. Carnevali, F., C. La Porta, V. Ilardi, and E. Beccari. 1989. Nuclear factors specifically bind to upstream sequences of a Xenopus laevis ribosomal protein gene promoter. Nucleic Acids Res. 17:8171-8184.
37. Metzger, W. and H. Heumann. 2001. Footprinting with exonuclease III, p. 39-47. In T. Moss (Ed.), Methods in Molecular Biology, vol. 148. DNA-Protein Interactions: Principles and Protocols, 2nd ed. Humana Press, Totowa, NJ.
38. Delage, V., J.M. Teulon, L. Bellanger, P. Seguin, F. Descotes, and S. Saez. 1996. Microtiter plate immunoenzymometric assay for estrogen receptor. Clin. Chem. 42:1955-1960.
39. Damberg, M., J. Ekblom, and L. Oreland. 2000. Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2. Life Sci. 68:669-678.
40. Pokroy, R., Y. Tendler, A. Pollack, O. Zinder, and G. Weisinger. 2002. p53 Expression in the normal murine eye. Invest. Ophthalmol. Vis. Sci. 43:1736-1741.
41. Harada, Y.N., N. Shiomi, M. Koike, M. Ikawa, M. Okabe, S. Hirota, Y. Kitamura, M. Kitagawa, et al. 1999. Postnatal growth failure, short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene. Mol. Cell. Biol. 19:2366-2372.
42. Weisinger, G., Y. Tendler, and O. Zinder. 2000. Quantification of p53 expression in the nervous system. Brain. Res. Brain. Res. Protoc. 6:71-79.
43. Schwarzenberg-Bar-Yoseph, F., M. Armori, and E. Karnieli. 2004. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 64:2627-2633.
44. Frantz, S., D. Fraccarollo, H. Wagner, T.M. Behr, P. Jung, C.E. Angermann, G. Ertl, and J. Bauersachs. 2003. Sustained activation of nuclear factor kappa B and activator protein I in chronic heart failure. Cardiovasc. Res. 57:749-756.
45. McKay, I.A., L. Kirby, E.V. Volyanik, V. Kumar, P.W. Wong, and S.A. Bustin. 1998. An enzyme-linked immunosorbent assay for the detection of agents which interfere with the DNA binding activities of transcription factors-exemplified by NF-IL6. Anal. Biochem. 265:28-34.
46. Benotmane, A.M., M.F. Hoylaerts, D. Collen, and A. Belayew. 1997. Nonisotopic quantitative analysis of protein-DNA interactions at equilibrium. Anal. Biochem. 250:181-185.
47. Gubler, M.L. and P. Abarzua. 1995. Nonradioactive assay for sequence-specific DNA binding proteins. BioTechniques 18:1008-1014.
48. Jagelska, E., V. Brazda, S. Pospisilova, B. Vojtesek, and E. Palecek. 2002. New ELISA technique for analysis of p53 protein/DNA binding properties. J. Immunol. Methods 267:227-235.
49. Bulyk, M.L., E. Gentalen, D.J. Lockhart, and G.M. Church. 1999. Quantifying DNA-protein interactions by double-stranded DNA arrays. Nat. Biotechnol. 17:573-577.
50. Bulyk, M.L., X. Huang, Y. Choo, and G.M. Church. 2001. Exploring the DNA-binding specificities of zinc fingers with DNA microarrays. Proc. Natl. Acad. Sci. USA 98:7158-7163.
51. Wang, J.K., T.X. Li, V.F. Bai, and Z.H. Lu. 2003. Evaluating the binding affinities of NF-κB p50 homodimer to the wild-type and single-nucleotide mutant Ig-κB sites by the unimolecular dsDNA microarray. Anal. Biochem. 316:192-201.
52. Egener, T., E. Roulet, M. Zehnder, P. Bucher, and N. Mermod. 2005. Proof of concept for microarray-based detection of DNA-binding oncogenes in cell extracts. Nucleic Acids Res. 33:e79.
53. Linnell, J., R. Mott, S. Field, D.P. Kwiatkowski, J. Ragoussis, and I.A. Udalova. 2004. Quantitative high-throughput analysis of transcription factor binding specificities. Nucleic Acids Res. 32:e44.
54. Baldwin, A.S. 2001. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J. Clin. Invest. 107:241-246.
55. Ko, L.J. and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
56. van den Berg, R., G.R. Haenen, H. van den Berg, and A. Bast. 2001. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br. J. Nutr. 86:S121-S127.
57. Harant, H., B. Wol, and I.J.D. Lindley. 1998. 1α, 25-Dihydroxyvitamin D3 decreases DNA binding of nuclear factor-κB in human fibroblasts. FEBS Lett. 436:329-334.